Novel quinazoline-based sulfonamide derivative (3D) induces apoptosis in colorectal cancer by inhibiting JAK2–STAT3 pathway
Introduction: Colorectal cancer (CRC) is a major worldwide health problem owing to its high prevalence and mortality rate. Developments in screening, prevention, biomarker, personalized therapies and chemotherapy have improved detection and treatment. However, despite these advances, many patient...
Similar Items
-
Novel derivative of aminobenzenesulfonamide (3c) induces apoptosis in colorectal cancer cells through
ROS generation and inhibits cell migration
by: Al-Khayal, Khayal A., et al.
Published: (2017) -
Synthesis and evaluation of anticancer, antiphospholipases, antiproteases, and antimetabolic syndrome activities of some 3H-quinazolin-4-one derivatives
by: El-Sayed, Nahed Nasser Eid, et al.
Published: (2019) -
Development of certain new 2-substituted-quinazolin-4-yl-aminobenzenesulfonamide as potential antitumor agents
by: Alafeefy, Ahmed Mahmoud, et al.
Published: (2016) -
Intro stats
by: De Veaux
Published: (2006) -
Synthesis 4-[2-(2-mercapto-4-oxo-4H-quinazolin-3-yl)-ethyl]-benzenesulfonamides with subnanomolar carbonic anhydrase II and XII inhibitory properties
by: Bozdag, Murat, et al.
Published: (2016)